From: Progress and perspectives of enzymatic preparation of human milk fat substitutes
Reaction type | Step 1 | Step 2 | Yield | Ref. | ||
---|---|---|---|---|---|---|
Substrates | Catalyst | Substrates | Catalyst | |||
Acidolysis–acidolysis | Tuna oil/PA | Novozym 435 | TAGs/FFAs rich in OA | Lipase DF | sn-2 PA, sn-2 DHA content: 52.1%, 15.4%, sn-1,3 OA content: 67% | [44] |
Transesterification–transesterification | Hazelnut oil + ethyl palmitate | Novozym 435 | TAGs/ARA/DHA-rich single-cell oils | Lipozyme RM IM | PA, ARA, DHA content: 58.9%, 2.7%, 1.5%; sn-2 PA content: 62.5% | [43] |
Acidolysis–transesterification | Camellia seed oil + PA | Novozym 435 | TAGs/fish oil | Lipozyme TL IM | PA, EPA, DHA, ARA content: 27.88%, 14.50%, 7.38%, 0.99%; sn-2 PA content: 55.97% | [49] |
Alcoholysis–transesterification | Tripalmitin + ethanol | Candida sp. 99–125 lipase | 2-MAG/ethyl oleate | Candida sp. 99–125 lipase | OPO content: 85.06%; sn-2 PA content: 80.17% | [46] |
Alcoholysis–acidolysis | Lard + ethanol | Novozym 435 | (Lard + 2-MAG)/(OA + LA) | Lipozyme RM IM | TAG recovery: 66.2 mol%; sn-2 PA content: 66.8% | [45] |
Fish oil + ethanol | Novozym 435 | 2-MAG/OA | Lipozyme RM IM | sn-1,3-OA-sn-2-PUFA-TAG yield: 86.3% | [50] | |
Lard + ethanol | Novozym 435 | (Lard + 2-MAG)/(OA/LA/Ln, 5:2:1, mol) | Lipozyme RM IM | Non-PUFA-containing HMFS yield: 71.3% | ||
Alcoholysis–(acidolysis and transesterification) | Lard + ethanol | Novozym 435 | (Lard + 2-MAG)/(OA/LA/Ln, 5:2:1, mol, and PUFA-EEs) | Lipozyme RM IM | sn-1,3-PUFA-HMFS (10% PUFAs at sn-1,3 positions) yield: 69.4% | |
Esterification–esterification | Glycerol + OA | Novozym 435 | Products in step 1/PA | Novozym 435 | OPO yield: 15.02%; C52 content: 38.55 wt%; sn-2 PA content: 39.06% | [47] |
Esterification–acidolysis | Glycerol + PA | NaOH | Tripalmitin/OA | Lipozyme RM IM | OPO content: 40.23%; 86.62% PA at sn-2 position, 63.74% OA at sn-1,3 positions | [48] |
Lipozyme TL IM | OPO content: 32.34%; 92.92% PA at sn-2 position |